Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

157 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 33,769,857 shares of 202,731,676 outstanding shares and own 16.7% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (4,950,000 shares), STATE STREET CORP (4,111,794 shares), VANGUARD GROUP INC (3,749,286 shares), BlackRock Inc. (3,249,001 shares), Alpine Global Management, LLC (3,000,200 shares), TWO SIGMA INVESTMENTS, LP (1,144,311 shares), EcoR1 Capital, LLC (1,140,819 shares), TWO SIGMA ADVISERS, LP (1,008,500 shares), MORGAN STANLEY (865,225 shares), and GEODE CAPITAL MANAGEMENT, LLC (855,908 shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.